Genetic testing platform PleSSision-Exome, a DNA sequencing system that covers more than 19,000 different genes, could help expand personalized cancer medicine in Japan. Developed by Hiroshi ...

Rare diseases often remain undiagnosed due to unknown etiologies. In recent years, researchers have made headway in characterizing the molecular causes of rare diseases thanks to progressively ...

The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...

next-generation sequencing and machine learning for full tumor exome analysis" has been published in Oncotarget. About 7% of all cancer deaths are caused by pancreatic cancer (PCa). PCa is known ...

Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received ...

Scientists are devising new ways to overcome this obstacle for RNA sequencing. RNA is more subject to degradation ... pair with their other target enrichment solutions such as the RNA Exome panel ...

Wolff's case was published in the New England Journal of Medicine as an early example of precision cancer treatment. Nearly 10 years later, researchers can sequence a person's entire genome in ...

Her research focuses on understanding genetic risk of prostate cancer in multi-ancestry populations, particularly using rare variants captured with whole exome sequencing, genome-wide association ...